Barclays
Barclays is a British universal bank headquartered in London. Its investment bank publishes equity research on about 1,800 stocks across the Americas and Europe, with a US equities business built on the Lehman Brothers operations it acquired in 2008.
Activity24M
RatingsPrice targetsKey figures
- Stocks covered
- 1,26412M
- Actions
- 7,71112M
- Ratings / Price targets
- 4,340 / 3,371
- Upgrades / Downgrades
- 174 / 183
- Initiations
- 47
- Buy-rated
- 55%of 1,227 rated
- Median upside
- +11.9%
- Targets raised / lowered
- 1,913 / 1,137
- On record
- Feb 2012 – Sep 2026
Overview
Barclays Research has more than 230 senior analysts covering about 1,800 stocks and over 500 credit issuers (2026), and ranked among the top three for Developed Europe research in Extel's 2026 survey.
Barclays traces its origins to a goldsmith bank opened on Lombard Street in London in 1690. In 1896, 20 banks merged to form Barclay and Company Limited. Barclays formed the investment bank Barclays de Zoete Wedd in 1986 and agreed to sell BZW's equities and corporate finance businesses to Credit Suisse First Boston in 1997, retaining the debt business as Barclays Capital. Its 2008 acquisition of Lehman Brothers' North American businesses restored its US equities and research operations. The unit now operates as Barclays Investment Bank.
Milestones
- 1690
Freame and Gould open goldsmith bank on Lombard Street
- 1896
Twenty banks amalgamate as Barclay and Company Limited
- 1986
Barclays de Zoete Wedd investment bank formed
- 1997
Agrees to sell BZW equities business to CSFB; forms Barclays Capital
- 2008
Acquires Lehman Brothers' North American businesses
Firm facts
- Legal name
- Barclays PLC
- Type
- Bulge bracket
- Founded
- 1690
- Headquarters
- London, United Kingdom
- Listing
- NYSE: BCS
- Group Chief Executive
- C.S. Venkatakrishnan
- Rating scale
- OverweightEqual WeightUnderweight12 months
- Website
- home.barclays
Research philosophy
Combining deep sector expertise and data-driven analysis, our Equity Research analysts uncover trends and catalysts shaping global equities.
Barclays says its data science researchers work with sector analysts to incorporate alternative data, AI and machine learning into investment analysis. Its Quantitative Portfolio Strategy group advises clients on portfolio construction, risk allocation and systematic investing. In April 2026, global head of research Brad Rogoff described data science and AI as central to the firm's research business.
Rating methodology
Stocks are rated Overweight, Equal Weight or Underweight against the analyst's industry coverage universe over a 12-month horizon; separate industry views are Positive, Neutral or Negative.
Coverage12M
Sectors
Most covered24M
| Stock | Rating | Target |
|---|---|---|
Honeywell International Inc.HON | Overweight | $239 |
Humana Inc.HUM | Equal Weight | $407 |
Interactive Brokers Group, Inc.IBKR | Overweight | $114 |
Invesco Ltd.IVZ | Equal Weight | $32 |
Marex Group plc Ordinary SharesMRX | Overweight | $86 |
PepsiCo, Inc.PEP | Equal Weight | $142 |
Constellation Brands, Inc.STZ | Equal Weight | $122 |
BlackRock, Inc.BLK | Overweight | $1,450 |
Coinbase Global, Inc.COIN | Underweight | $95 |
Hilton Worldwide Holdings Inc.HLT | Overweight | $368 |
Most active analysts
- Tom O'Malley97 notesMUCRUSCRDO
- Benjamin Budish67 notesVRTSMRXBX
- Raimo Lenschow67 notesDDOGNOWORCL
- Richard Hightower62 notesCPTESSO
- Julian Mitchell60 notesPNRHONTT
- Alex Scott56 notesPRUUNMALL
Recent actions
| Date | Stock | Rating action | Rating | Target | Analyst |
|---|---|---|---|---|---|
| Sep 22 | Constellation Brands, Inc.STZ | Reiterate | Equal Weight | $132 →$122 | Lauren Lieberman |
| Sep 22 | Abivax S.A.ABVX | Reiterate | Overweight | ||
| Sep 21 | RAUltragenyx Pharmaceutical Inc.RARE | Target | $32 →$35 | ||
| Sep 21 | PAPlains GP Holdings, L.P.PAGP | Reiterate | Underweight | $23 →$24 | |
| Sep 21 | PAPlains All American Pipeline, L.P.PAA | Reiterate | Underweight | $23 →$24 | Theresa Chen |
| Sep 21 | CDCDW CorporationCDW | Reiterate | Equal Weight | ||
| Sep 18 | DTDynatrace, Inc.DT | Initiate | Overweight | ||
| Sep 18 | HECybin Inc. Common StockHELP | Initiate | Overweight | $35 |











